Skip to content
Clinical Trial Events
BIO-Europe 2026

Panel Regulatory Strategy track

Regulatory Updates for Orphan and Pediatric Medicines

Tue, Nov 10, 2026 · 10:00–10:25 AM CET Regulatory Strategy Stage, Koelnmesse

About this session

Examining the enhanced incentives under updated GPL regulations Understanding the baseline for data protection measures How to qualify for rewards attached to new indications with significant clinical benefits Analysing breakthrough definition for extending exclusivity periods Key updates tailored to paediatric medicine advancements

Speaker

  • Katherine Tyner

    Senior Director, Regulatory Policy Leader, EMEA & CMC · Johnson & Johnson

    Panelist